Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity.

Arthritis Res Ther · 2010 · PMC2911854 · PMID 20459619

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

We observed that the DAS at the time of therapy discontinuation showed a trend to decrease over time. status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Received 2009 Nov 26; Revised 2010 Apr 21; Accepted 2010 May 6; Issue date 2010.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.